• Pitt
  • Health Sciences
  • UPMC
Regenerative Medicine at the McGowan InstituteRegenerative Medicine at the McGowan InstituteRegenerative Medicine at the McGowan InstituteRegenerative Medicine at the McGowan Institute
  • Home
  • Our People
    • Faculty/Staff Bios
    • Core Faculty Publications
    • Administrative Resources
  • Our Technologies
  • About Us
    • Welcome
    • Video
    • Mission Statement
    • What Is Regenerative Medicine?
    • Executive Committee
    • Contact Us
    • Clinical Site
  • Our Research
    • Focus Areas
      • Tissue Engineering and Biomaterials
      • Cellular Therapies
      • Medical Devices and Artificial Organs
      • Clinical Translation
    • Matrix
    • Centers
    • Laboratories
    • Clinical Trials
    • Initiatives
  • Media
    • Current News
    • News Archive
    • Video
    • Podcasts
    • Newsletter
    • Grant of the Month
    • Publication of the Month
    • Media Contact
    • Video Links
  • Professional Development
    • Seminar Series
    • Special Events
    • Student Interest Groups
    • CATER
    • Post-Doctoral Opportunities
    • Career Opportunities
    • Wiegand Summer Internship
    • Admissions
    • Summer School
    • 2022 Scientific Retreat

Home Articles posted by The McGowan Institute For Regenerative Medicine

Hepato-Healing: A Treatment from Within

By The McGowan Institute For Regenerative Medicine | Cellular Therapy, Current News, Featured News | May 11, 2022

The same technology used in COVID-19 vaccines holds promise as a new approach to liver disease treatment. Michele Dula Baum, Senior Writer/Project Manager, Strategic Communications, Office of the Senior Vice Chancellor, Health Sciences, reports in PittMed where the science is heading in this new therapy methodology. Read More

Cardiomyopathy Leads to Heart Transplantation for Sharpsville Man

By The McGowan Institute For Regenerative Medicine | Current News, Featured News, Transplantation | May 11, 2022

Cardiomyopathy is a disease that affects the heart muscle. In cardiomyopathy, the damaged heart muscle becomes enlarged, thick, or rigid, and cannot pump blood effectively. It’s the leading cause of heart failure and the most common reason for needing a heart transplant. Unlike other heart problems, cardiomyopathy frequently affects younger people. Read More

Illumination of Immune Checkpoint LAG3 ‘Black Box’ Could Yield New Cancer and Autoimmune Therapies

By The McGowan Institute For Regenerative Medicine | Cancer, Current News, Epidemiology, Featured News | May 11, 2022

Fighting cancer and chronic disease is tiring work for the immune system. When T cells are engaged in this kind of lengthy battle, they can become exhausted, or unable to function properly. One immunotherapy that revitalizes these cells by blocking an immune checkpoint protein called LAG3 was recently approved by federal regulators. But exactly how LAG3 works has remained a mystery — until now. Read More

Dr. Steffi Oesterreich Named Shear Family Endowed Chair in Breast Cancer Research

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News, Featured News | May 11, 2022

The Lee/Oesterreich Lab of the Magee-Women’s Research Institute is headed by the husband/wife team of Adrian Lee, PhD (pictured left), Professor of Pharmacology & Chemical Biology and Human Genetics, and Director, Institute for Precision Medicine, and Steffi Oesterreich, PhD (pictured right), Professor & Vice Chair, Precision and Translational Pharmacology, and Co-Director of the Women’s Cancer Research Center. Dr. Oesterrich is also an affiliated faculty member of the McGowan Institute for Regenerative Medicine. Read More

Dr. William Wagner Named 2022-2023 President-Elect for the Society For Biomaterials

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News, Featured News | May 5, 2022

The Society For Biomaterials hosted its 2022 Annual Meeting at the Baltimore Marriott Waterfront, April 27-30, 2022. The theme for the 2022 Annual Meeting was “The Perilous Fight to Translate Innovative Research to Commercial Viability.” This year’s program focused on ideas that involve breakthroughs in biomaterials science, translation of basic research to clinical application, next-generation medical devices, and content that explores standards development, regulatory issues, and commercial realities. Read More

Dr. Eva Lai Joins Pitt’s Swanson School as Director for Partnerships and Innovations

By The McGowan Institute For Regenerative Medicine | Current News, Education, Featured News | May 5, 2022

Eva Lai, PhD, made a site visit to the University of Pittsburgh in 2006 when she was building a national research program for regenerative medicine for the U.S. Department of Defense (DoD) to address wounded warriors’ injuries. The program was the Armed Forces Institute of Regenerative Medicine (AFIRM) that resulted in over $200 million in research investments. AFIRM, a multi-institutional, interdisciplinary network working to develop advanced treatment options for our severely wounded servicemen and women, is ongoing. McGowan Institute for Regenerative Medicine Director William Wagner, PhD, is its Chief Science Officer in the collaborative AFIRM effort of the Wake Forest Institute of Regenerative Medicine and the McGowan Institute. Read More

New Hope for Predicting and Treating Heart Failure in Babies Born with Deadly Heart Defect

By The McGowan Institute For Regenerative Medicine | Cellular Therapy, Current News, Featured News | May 5, 2022

Almost one third of babies born with hypoplastic left heart syndrome, or HLHS, die from heart failure before their first birthday. By uncovering cellular processes that drive heart failure in these young patients, a new study may hold the answers to identifying and treating those at highest risk of early death. Read More

Sensing Signals in Paralyzed Muscles

By The McGowan Institute For Regenerative Medicine | Current News, Featured News, Medical Devices | May 5, 2022

For people with tetraplegia—a condition in which all four limbs have lost motor ability—regaining independence is a top priority. Although there is no cure for paralysis caused by neurological disorders, robotic arms and exoskeletons may provide some assistance. Controlling these robotic devices, however, is a complex problem. Researchers have experimented with voice control (which struggles to translate verbal commands into a three-dimensional space), brain-computer interfaces (which require complex surgery), and joysticks (which often mean multiple rounds of positioning for each arm segment). Read More

Drs. Kacey Marra and Eric Lagasse Recognized During Pitt’s Celebration of Innovation

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News, Featured News | April 27, 2022

The University of Pittsburgh Office of Innovation and Entrepreneurship presented its 2022 Celebration of Innovation on April 21, 2022. This event recognized the achievements of Pitt faculty and student innovators who are seeking to improve people’s lives through the commercialization of their ideas and discoveries. In addition to recognizing all faculty and students who submitted an invention disclosure, were issued a U.S. patent, or had their innovation licensed, there were seven special awards presented. The efforts of two McGowan Institute for Regenerative Medicine faculty members were recognized among these special awards. Read More

Upcoming Stentrode Trial in Pittsburgh to Help Patients with Quadriparesis

By The McGowan Institute For Regenerative Medicine | Current News, Featured News, Medical Devices | April 27, 2022

Four paralyzed people in Australia can now operate a computer using only their thoughts thanks to a brain implant developed in part by Carnegie Mellon University’s Douglas Weber, PhD, Professor of Mechanical Engineering and Neuroscience and an affiliated faculty member of the McGowan Institute for Regenerative Medicine. Emily Mullin, Pittsburgh Post-Gazette, recently spoke with Dr. Weber on the status of this brain-computer interface. Read More

Department of Physical Therapy Professor Named a Gerontological Society of America Fellow

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News, Featured News | April 27, 2022

McGowan Institute for Regenerative Medicine affiliated faculty member Jessie VanSwearingen, PhD, PT, Professor of Physical Therapy in the School of Health and Rehabilitation Sciences, was named a Fellow of the Gerontological Society of America (GSA) for her outstanding contributions to the group. Read More

ISHLT Names Newly Elected Professional Community Leaders

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News, Featured News | April 27, 2022

The International Society of Heart and Lung Transplantation (ISHLT) has announced the results of the 2022 member elections for Professional Community Leaders, who serve as representatives to the four ISHLT Interdisciplinary Network Steering Committees. Seventeen leaders across seven professional specialties were elected to serve three-year terms beginning May 1, 2022, immediately following the 2022 ISHLT Annual Meeting.  Two of the 17 leaders elected are McGowan Institute for Regenerative Medicine affiliated faculty members: Read More

Publication of the Month | April 2022

By The McGowan Institute For Regenerative Medicine | Publication of the Month, Publication of the Month 2022 | April 27, 2022

Author: Xinxiu Xu, Kang Jin, Abha S. Bai, Wenjuan Zhu, Hisato Yagi, Timothy N. Feinstein, Phong K. Nguyen, Joseph D. Criscione, Xiaoqin Liu, Gisela Beutner, Kalyani B. Karunakaran, Krithika S. Rao, Haoting He, Phillip Adams, Catherine K. Kuo, Dennis Kostka, Gloria S. Pryhuber, Sruti Shiva, Madhavi K. Ganapathiraju, George A. Porter Jr., Jiuann-Huey Ivy Lin, Bruce Aronow, Cecilia W. Lo Read More

Grant of the Month | April 2022

By The McGowan Institute For Regenerative Medicine | Grant of the Month, Grant of the Month 2022 | April 27, 2022

PI: Donghun Shin

Title: Delineating the molecular mechanisms of hepatocyte-to-cholangiocyte reprogramming Read More

Newsletter | April 2022

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2022 | April 27, 2022

Drs. Kacey Marra (top) and Eric Lagasse

April 2022 | VOL. 21, NO. 4| www.McGowan.pitt.edu

Drs. Kacey Marra and Eric Lagasse Recognized During Pitt’s Celebration of Innovation

The University of Pittsburgh Office of Innovation and Entrepreneurship presented its 2022 Celebration of Innovation on April 21, 2022. This event recognized the achievements of Pitt faculty and student innovators who are seeking to improve people’s lives through the commercialization of their ideas and discoveries. In addition to recognizing all faculty and students who submitted an invention disclosure, were issued a U.S. patent, or had their innovation licensed, there were seven special awards presented. The efforts of two McGowan Institute for Regenerative Medicine faculty members were recognized among these special awards. Read More

CATER Trainee George Gabriel Defends Dissertation

By The McGowan Institute For Regenerative Medicine | CATER | April 20, 2022

CATER Trainee George Gabriel defended his dissertation on Thursday, April 14, 2022. The presentation was titled,  “Genetic and Epigenetic Basis for Brain Abnormalities and Neurobehavioral Deficits in a Mouse Model of Hypoplastic Left Heart Syndrome.” Read More

EV2 Technologies Takes 2nd Place in 2022 Randall Family Big Idea Competition, Wins $15K Prize

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | April 20, 2022

EV2 Technologies’ Biocarpet is a flexible and fully biodegradable endovascular device that uses a special thermoforming technique and provides treatment of peripheral arterial disease in small arteries and across joints. The team’s approach minimizes vascular wall stress thus reducing restenosis. This technology was developed in the laboratories of the McGowan Institute for Regenerative Medicine and won the $15,000 prize at the 2022 Randall Family Big Idea Competition.  Collaborators on this effort include: Read More

Dr. Ernest Manders Receives Scientific Achievement Award

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News | April 20, 2022

The Scientific Achievement Award sponsored by Thermo Fisher Scientific Inc. and awarded by Life Sciences PA recognizes a scientist in the Pennsylvania life sciences community who has demonstrated outstanding achievement by advancing scientific knowledge, innovation, and/or patient care in their lifetime. McGowan Institute for Regenerative Medicine affiliated faculty member Ernest Manders, MD, Professor of Plastic Surgery (Emeritus), Department of Plastic Surgery, University of Pittsburgh, received this year’s award. Read More

Podcast: Cellular and Molecular Engineering in Orthopaedic Research with Dr. Peter Alexander

By The McGowan Institute For Regenerative Medicine | Cellular Therapy, Current News | April 20, 2022

McGowan Institute for Regenerative Medicine affiliated faculty member Peter Alexander, PhD, is the Assistant Director of the Center for Cellular and Molecular Engineering and an Assistant Professor in the Department of Orthopaedic Surgery both within the University of Pittsburgh. His background includes research in developmental biology, mechanisms of teratology and reproductive toxicology, orthopaedic surgery, stem cell biology, and tissue engineering. Common themes that run through active areas of his research are the use of stem cells in tissue engineering either as a participant or mediator of regenerative processes, the development of in vitro and/or in vivo models with which to test specific cell and tissue interactions, developmental or pathogenic processes, and the use of bioreactors to recapitulate specific cell and tissue interactions to produce physiological systems that more faithfully report disease processes and therapeutic outcomes. Read More

Welcome: Dr. Ramakrishna Mukkamala

By The McGowan Institute For Regenerative Medicine | Cellular Therapy, Current News | April 20, 2022

The McGowan Institute for Regenerative Medicine welcomes new affiliated faculty member Ramakrishna Mukkamala, PhD. Read More

R01 Grant Received for Research of Cholestatic Liver Diseases

By The McGowan Institute For Regenerative Medicine | Current News, Transplantation | April 13, 2022

Liver transplantation is the only effective treatment for patients with end-stage liver diseases; however, the shortage of donor livers makes this therapy very limited. Comprehensive and detailed understanding of innate liver regeneration in diseased livers will provide significant insights into developing therapeutic strategies to promote liver regeneration in the patients. Our studies will delineate the molecular mechanisms underlying hepatocyte-to-cholangiocyte reprogramming-mediated biliary regeneration and suggest HDAC1/2 inhibitors as promising therapeutic drugs to promote the reprogramming-mediated regeneration in patients with cholestatic liver diseases. Read More

Podcast: A History of Mechanical Circulatory Support of the Heart with Dr. Harvey Borovetz

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | April 13, 2022

After receiving his BA in Physics from Brandeis University in 1969, McGowan Institute for Regenerative Medicine faculty member Harvey Borovetz, PhD, went on to earn an MS and a PhD degree, both in bioengineering, from Carnegie Mellon University in 1973 and 1976, respectively. Today, he is a Distinguished Professor and former Chair (2002-2013) in the Department of Bioengineering, Swanson School of Engineering at the University of Pittsburgh; the Robert L. Hardesty Professor in the Department of Surgery, University of Pittsburgh School of Medicine; a Professor of Chemical and Petroleum Engineering; a Professor in the Clinical and Translational Science Institute; and a University Honors College Faculty Fellow. Dr. Borovetz’s current research interests focus on the design and clinical utilization of cardiovascular organ replacements for both adult and pediatric patients. Read More

Bone Super Glue Travels to Space

By The McGowan Institute For Regenerative Medicine | Current News, International Space Station | April 13, 2022

Since 2014, the International Space Station (ISS) National Laboratory has partnered with Boeing to award grants through an annual MassChallenge “Technology in Space Prize,” which supports startups with ideas for innovative research and development onboard the ISS National Laboratory. Boeing reported in SpaceNews about RevBio, a Lowell, Mass.-based medical device company that makes a patented bone adhesive called Tetranite, which fixes fractures and accelerates bone repair—especially in patients suffering from osteoporosis. After learning that even a short stay in microgravity can cause loss of bone mass, the company entered the “Technology in Space” competition and was awarded the prize in 2015. Read More

Welcome: Dr. Hamza Yazdani

By The McGowan Institute For Regenerative Medicine | Cancer, Current News | April 13, 2022

The McGowan Institute for Regenerative Medicine welcomes new affiliated faculty member Hamza Yazdani, MD. Read More

Podcast: DARPA “Mini-Manhattan Project” for Wound Healing with Dr. Stephen Badylak

By The McGowan Institute For Regenerative Medicine | Current News, Tissue Engineering | April 6, 2022

Led by the McGowan Institute for Regenerative Medicine Deputy Director Stephen Badylak, DVM, PhD, MD, a multi-institution research team secured a $22 million grant from the Defense Advanced Research Projects Agency (DARPA) in 2020 to develop a device combining artificial intelligence, bioelectronics, and regenerative medicine to regrow muscle tissue, especially after combat injuries. This 4-year DARPA opportunity, a “mini-Manhattan Project” for wound healing, is a cross-disciplinary project including researchers at Carnegie Mellon University, Northwestern University, Rice University, University of Vermont, University of Wisconsin, and Walter Reed National Military Medical Center in addition to the University of Pittsburgh. Read More

Treatment Correcting Night Blindness in Dogs Offers Hope for Treating Similar Condition in People

By The McGowan Institute For Regenerative Medicine | Current News, Vision | April 6, 2022

People with congenital stationary night blindness (CSNB) are unable to distinguish objects in dim-light conditions. This impairment presents challenges, especially where artificial lighting is unavailable or when driving at night. Read More

Dr. Dan Ding: New Tech Making Fitness More Accessible to People of All Abilities

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News | April 6, 2022

Pittsburgh tech and education leaders at this year’s South by Southwest (SXSW) festival, held in Austin, Texas, March 6-20, 2022, were recognized by Sophie Burkholder, a Staff Writer for Technical.ly, a news organization that serves a community of technology professionals, including entrepreneurs, technologists, and their supporters. This is the first in-person SXSW since 2020. Read More

April is Donate Life Month

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News, Transplantation | April 6, 2022

McGowan Institute for Regenerative Medicine affiliated faculty member George Mazariegos, MD, pediatric liver and intestine transplant surgeon and the Director of the Hillman Center for Pediatric Transplantation at the Children’s Hospital of Pittsburgh of UPMC, spoke to Ellis Cannon of WPXI/Pittsburgh in support of April’s Donate Life Month. The video interview is a part of the station’s UPMC/WPXI Community Matters segment. Read More

Newsletter | March 2022

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2022 | March 31, 2022

March 2022 | VOL. 21, NO. 3| www.McGowan.pitt.edu

Dr. David Kaczorowski on Xenotransplantation

McGowan Institute for Regenerative Medicine affiliated faculty member David Kaczorowski, MD, Surgical Director of the Advanced Heart Failure Center of UPMC Heart and Vascular Institute and an Associate Professor of Cardiothoracic Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, was a member of the surgical team on the historic first successful transplant of a porcine heart into an adult human with end-stage heart disease. As a follow-up to this extraordinary accomplishment by the surgical team, Dr. Kaczorowski published an article entitled, “Organs from genetically engineered pigs may help shorten the transplant wait list,” in The Conversation. The article focuses on the history of xenotransplantion, or transplanting animal organs into human beings. The article is repeated here: Read More

Podcast: In-Space Production of Biomanufacturing with Ms. Christine Kretz and Dr. William Wagner

By The McGowan Institute For Regenerative Medicine | Current News, International Space Station | March 30, 2022

The International Space Station (ISS) U.S. National Laboratory and the McGowan Institute for Regenerative Medicine (MIRM) are working on a multi-year research alliance to push the limits of biomedical research and development aboard the orbiting laboratory. The alliance — a core element of the ISS National Laboratory Industrial Biomedicine Program — serves as a benchmark for how the ISS National Laboratory develops similar programs in the future involving research and development activities aboard the space station. Read More

Newly Issued Patents for McGowan Institute Affiliated Faculty Members

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News | March 30, 2022

During the month of February 2022, University of Pittsburgh innovators were issued eight U.S. patents.  Five of those patents were based on research work conducted by McGowan Institute for Regenerative Medicine affiliated faculty members.  Their newly issued patents include: Read More

Dr. Stefanie Sydlik Named Member of CMU’s Inaugural Class of Tartans on the Rise

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News | March 30, 2022

McGowan Institute for Regenerative Medicine affiliated faculty member Stefanie Sydlik, PhD, Associate Professor of Chemistry and Biomedical Engineering at Carnegie Mellon University (CMU), was named a member of CMU’s inaugural class of Tartans on the Rise.  Tartans on the Rise celebrates recent alumni who are making an impact in their organizations and in their communities, across the nation and around the world through leadership, innovation, and career achievements. This year’s Tartans on the Rise class represents a diverse and talented alumni body that is working to elevate industries, communities, and people everywhere. Read More

Grant of the Month | March 2022

By The McGowan Institute For Regenerative Medicine | Grant of the Month, Grant of the Month 2022 | March 25, 2022

PI: Sruti Shiva

Co-PI: Anthony J. Molina

Title: The relationship between blood based bioenergetics and muscle function, mobility, and aging Read More

Publication of the Month | March 2022

By The McGowan Institute For Regenerative Medicine | Publication of the Month, Publication of the Month 2022 | March 25, 2022

Author: Michel Modo, Harmanvir Ghuman, Reem Azar, Ryan Krafty, Stephen F Badylak, T Kevin Hitchens

Title: Mapping the acute time course of immune cell infiltration into an ECM hydrogel in a rat model of stroke using 19 F MRI Read More

March is Women’s History Month

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News | March 23, 2022

Women’s History Month had its origins as a national celebration in 1981 when Congress passed Pub. L. 97-28 which authorized and requested the President to proclaim the week beginning March 7, 1982, as “Women’s History Week.” This continued throughout the next five years. In 1987 after being petitioned by the National Women’s History Project, Congress passed Pub. L. 100-9 which designated the month of March 1987 as “Women’s History Month.” Since 1988, presidents have issued a series of annual proclamations designating March as “Women’s History Month.” These proclamations celebrate the contributions women have made to the United States and recognize the specific achievements women have made over the course of American history in a variety of fields. Read More

Podcast: ECM and Tissue Reconstruction with Dr. George Hussey

By The McGowan Institute For Regenerative Medicine | Current News, Tissue Engineering | March 23, 2022

George Hussey, PhD, is an Assistant Professor in the University of Pittsburgh School of Medicine, Department of Pathology. Prior to joining the Department of Pathology, he was a Research Assistant Professor, McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, Department of Surgery.  He was also a McGowan Institute Postdoctoral Associate in the laboratory of Stephen Badylak, DVM, PhD, MD, and a Postdoctoral Fellow in the laboratory of Philip Howe, PhD, Hollings Cancer Center, Medical University of South Carolina, Charleston, Department of Biochemistry & Molecular Biology. Read More

CATER Trainee Kien Tran Defends Dissertation

By The McGowan Institute For Regenerative Medicine | CATER | March 22, 2022

CATER Trainee Kien Tran defended her dissertation on Monday, March 21, 2022. The presentation was titled, “Spermatogonial Stem Cells to Preserve and Restore Spermatogenic Potential.” Kien has also accepted a new position, a Stem Cell Scientist at Cellino Biotech, in Cambridge, Massachusetts. She will begin the new role in June 2022. Read More

Dr. David Kaczorowski on Xenotransplantation

By The McGowan Institute For Regenerative Medicine | Current News, Transplantation | March 16, 2022

McGowan Institute for Regenerative Medicine affiliated faculty member David Kaczorowski, MD, Surgical Director of the Advanced Heart Failure Center of UPMC Heart and Vascular Institute and an Associate Professor of Cardiothoracic Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, was a member of the surgical team on the historic first successful transplant of a porcine heart into an adult human with end-stage heart disease. As a follow-up to this extraordinary accomplishment by the surgical team, Dr. Kaczorowski published an article entitled, “Organs from genetically engineered pigs may help shorten the transplant wait list,” in The Conversation. The article focuses on the history of xenotransplantion, or transplanting animal organs into human beings. The article is repeated here: Read More

Dr. Cecelia Yates Receives Chancellor’s Distinguished Research Award

By The McGowan Institute For Regenerative Medicine | Awards and Recognition, Current News | March 16, 2022
Dr. Cecelia Yates

University of Pittsburgh Chancellor Patrick Gallagher recognized 15 faculty members — and one entire office — this year with Chancellor’s Distinguished Awards across three categories. McGowan Institute for Regenerative Medicine affiliated faculty member Cecelia Yates, PhD, associate professor in the Department of Health Promotion and Development, School of Nursing, was recognized in the Chancellor’s Distinguished Research Awards/Junior category for her research to understand the signaling networks that underlie pathologic fibrosis across multiple tissue and organ systems. Cited as a “rising star” in the field, Dr. Yates’ approach also includes developing therapeutics for diseases caused by this phenomenon. Read More

Investigating the Effects of Critical Illness in Early Childhood on Neurocognitive Outcomes

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices, Neuroscience | March 16, 2022

Approximately 23,700 children in the U.S. undergo invasive mechanical ventilation for acute respiratory failure annually. Although most survive, little is known if they have worse long-term neurocognitive function than children who do not undergo such procedures. There are concerns about neurotoxic effects of critical illness and its treatment on the developing brain. Therefore, infants and young children may be uniquely susceptible to adverse neurocognitive outcomes after invasive mechanical ventilation. Read More

123
  • site map
  • links
  • contact
  • subscribe to our newsletter
© Copyright 2021 McGowan Institute for Regenerative Medicine
A program of the University of Pittsburgh and the University of Pittsburgh Medical Center
  • Home
  • Our People
    • Faculty/Staff Bios
    • Core Faculty Publications
    • Administrative Resources
  • Our Technologies
  • About Us
    • Welcome
    • Video
    • Mission Statement
    • What Is Regenerative Medicine?
    • Executive Committee
    • Contact Us
    • Clinical Site
  • Our Research
    • Focus Areas
      • Tissue Engineering and Biomaterials
      • Cellular Therapies
      • Medical Devices and Artificial Organs
      • Clinical Translation
    • Matrix
    • Centers
    • Laboratories
    • Clinical Trials
    • Initiatives
  • Media
    • Current News
    • News Archive
    • Video
    • Podcasts
    • Newsletter
    • Grant of the Month
    • Publication of the Month
    • Media Contact
    • Video Links
  • Professional Development
    • Seminar Series
    • Special Events
    • Student Interest Groups
    • CATER
    • Post-Doctoral Opportunities
    • Career Opportunities
    • Wiegand Summer Internship
    • Admissions
    • Summer School
    • 2022 Scientific Retreat
Regenerative Medicine at the McGowan Institute